IN8bio (INAB) director Brandt received 253,164 shares

Insider transactions reported

Peter C. Brandt (director at IN8bio Inc., INAB) reported that they received 253,164 shares on Oct 4, 2024. After these transactions the filing shows 517,604 shares held directly.

Reporting person

Brandt Peter C.

Options and other derivatives

Holdings before and after

• Common Stock: 264,440 to 517,604 direct
• Series C Warrants (right to buy): 0 to 253,164 direct

Other positions listed

• Common Stock: 105,290 indirect, See footnote

Footnotes from the filing

1. 1. The reported securities are included within 253,164 Issuer Units purchased by the Reporting Person for $0.395 per Unit. Each Unit consists of one share of common stock and one Series C warrant representing the right to purchase 253,164 shares of common stock.
2. 2. The securities are held by The Peter C. Brandt 2020-4 GRAT (the GRAT ). The Reporting Person is the trustee of the GRAT and, as such, has voting and investment power over the shares held by the GRAT.
3. 3. The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the old warrant and the grant of a replacement warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.25 and expiration date of June 13, 2025. The exercise price was reduced to $0.45 and the warrant expiration date was extended to October 4, 2025.
4. 4. Fully vested and exercisable.
5. 5. The reported securities are included within 81,967 Issuer Units purchased by the Reporting Person for $1.22 per Unit. Each Unit consists of one share of common stock, one Series A warrant and one Series B warrant, each warrant represents the right to purchase 81,967 shares of common stock.

Transaction codes in this filing

Grant or award:

Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.

FAQ